ELI LILLY & Co — Director's Dealing 2024

Nov 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-11-01

Reporting Person: Montarce Lucas (EVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-01	Common Stock	M	1074	—	Acquired	11541	Direct
2024-11-01	Common Stock	F	467.196	$818.93	Disposed	11073.804	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-01	Restricted Stock Unit	$	M	1074	Disposed	2024-11-01	Common Stock (1074)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.